Skip to main content
. 2020 Nov 11;26(4):e549–e566. doi: 10.1002/onco.13577
All phases, All cycles Grade Total
NC/NA, % 1 2 3 4 5
Ipilimumab 3 mg/kg (n = 11), n (%)
Pruritus 55 3 (27.3) 2 (18.2) 0 0 0 5 (45.5)
Rash 55 3 (27.3) 2 (18.2) 0 0 0 5 (45.5)
Aspartate aminotransferase increased 64 3 (27.3) 1 (9.1) 0 0 0 4 (36.4)
Constipation 64 1 (9.1) 3 (27.3) 0 0 0 4 (36.4)
Cough 64 3 (27.3) 1 (9.1) 0 0 0 4 (36.4)
Malignant neoplasm progression 64 0 0 0 0 4 (36.4) 4 (36.4)
Weight decreased 64 2 (18.2) 2 (18.2) 0 0 0 4 (36.4)
Anemia 73 0 3 (27.3) 0 0 0 3 (27.3)
Decreased appetite 73 2 (18.2) 1 (9.1) 0 0 0 3 (27.3)
Nausea 73 3 (27.3) 0 0 0 0 3 (27.3)
Asthenia 82 2 (18.2) 0 0 0 0 2 (18.2)
Blood lactate dehydrogenase 82 0 2 (18.2) 0 0 0 2 (18.2)
Dizziness 82 2 (18.2) 0 0 0 0 2 (18.2)
Hypokalemia 82 0 0 2 (18.2) 0 0 2 (18.2)
Hyponatremia 82 0 0 1 (9.1) 1 (9.1) 0 2 (18.2)
Hypoproteinemia 82 1 (9.1) 1 (9.1) 0 0 0 2 (18.2)
Pain 82 1 (9.1) 1 (9.1) 0 0 0 2 (18.2)
Pyrexia 82 2 (18.2) 0 0 0 0 2 (18.2)
Vomiting 82 1 (9.1) 1 (9.1) 0 0 0 2 (18.2)
Abdominal pain 91 0 1 (9.1) 0 0 0 1 (9.1)
Alanine aminotransferase increased 91 0 1 (9.1) 0 0 0 1 (9.1)
Blood alkaline phosphatase increased 91 1 (9.1) 0 0 0 0 1 (9.1)
Blood creatinine increased 91 1 (9.1) 0 0 0 0 1 (9.1)
Chest discomfort 91 1 (9.1) 0 0 0 0 1 (9.1)
Chest pain 91 0 1 (9.1) 0 0 0 1 (9.1)
Dreamy state 91 1 (9.1) 0 0 0 0 1 (9.1)
Electrocardiogram QT prolonged 91 1 (9.1) 0 0 0 0 1 (9.1)
Emotional disorder 91 0 1 (9.1) 0 0 0 1 (9.1)
Fatigue 91 1 (9.1) 0 0 0 0 1 (9.1)
Flushing 91 1 (9.1) 0 0 0 0 1 (9.1)
Gamma‐glutamyltransferase increased 91 0 1 (9.1) 0 0 0 1 (9.1)
Gastrointestinal disorder 91 1 (9.1) 0 0 0 0 1 (9.1)
Hyperkalemia 91 0 1 (9.1) 0 0 0 1 (9.1)
Hyperthyroidism 91 1 (9.1) 0 0 0 0 1 (9.1)
Hypothyroidism 91 0 1 (9.1) 0 0 0 1 (9.1)
Insomnia 91 0 1 (9.1) 0 0 0 1 (9.1)
Mouth ulceration 91 1 (9.1) 0 0 0 0 1 (9.1)
Neurotoxicity 91 1 (9.1) 0 0 0 0 1 (9.1)
Otitis media 91 1 (9.1) 0 0 0 0 1 (9.1)
Pain in extremity 91 0 1 (9.1) 0 0 0 1 (9.1)
Pigmentation disorder 91 0 1 (9.1) 0 0 0 1 (9.1)
Platelet count increased 91 1 (9.1) 0 0 0 0 1 (9.1)
Pneumonia 91 0 1 (9.1) 0 0 0 1 (9.1)
Productive cough 91 1 (9.1) 0 0 0 0 1 (9.1)
Pruritus generalised 91 1 (9.1) 0 0 0 0 1 (9.1)
Skin disorder 91 0 1 (9.1) 0 0 0 1 (9.1)
Skin exfoliation 91 0 1 (9.1) 0 0 0 1 (9.1)
Somnolence 91 1 (9.1) 0 0 0 0 1 (9.1)
Tachypnoea 91 0 1 (9.1) 0 0 0 1 (9.1)
Thyroid disorder 91 1 (9.1) 0 0 0 0 1 (9.1)
Urine abnormality 91 0 1 (9.1) 0 0 0 1 (9.1)